These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 27998719)

  • 21. Site-specific consultation for a chemical mixture.
    Pohl HR; Roney N; Fay M; Chou CH; Wilbur S; Holler J
    Toxicol Ind Health; 1999 Aug; 15(5):470-9. PubMed ID: 10487358
    [TBL] [Abstract][Full Text] [Related]  

  • 22. REACH, non-testing approaches and the urgent need for a change in mind set.
    Schaafsma G; Kroese ED; Tielemans EL; Van de Sandt JJ; Van Leeuwen CJ
    Regul Toxicol Pharmacol; 2009 Feb; 53(1):70-80. PubMed ID: 19061930
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methods for assessing risks of dermal exposures in the workplace.
    McDougal JN; Boeniger MF
    Crit Rev Toxicol; 2002 Jul; 32(4):291-327. PubMed ID: 12184506
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Health and safety implications of occupational exposure to engineered nanomaterials.
    Stebounova LV; Morgan H; Grassian VH; Brenner S
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2012; 4(3):310-21. PubMed ID: 22131295
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Key principles and operational practices for improved nanotechnology environmental exposure assessment.
    Svendsen C; Walker LA; Matzke M; Lahive E; Harrison S; Crossley A; Park B; Lofts S; Lynch I; Vázquez-Campos S; Kaegi R; Gogos A; Asbach C; Cornelis G; von der Kammer F; van den Brink NW; Mays C; Spurgeon DJ
    Nat Nanotechnol; 2020 Sep; 15(9):731-742. PubMed ID: 32807878
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Connecticut physicians' knowledge and needs assessment of environmentally related health hazards--a survey.
    Szneke P; Nielsen C; Tolentino N
    Conn Med; 1994 Mar; 58(3):131-5. PubMed ID: 8039379
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Toxicity testing of nanomaterials.
    Schrand AM; Dai L; Schlager JJ; Hussain SM
    Adv Exp Med Biol; 2012; 745():58-75. PubMed ID: 22437813
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Moving toward exposure and risk evaluation of nanomaterials: challenges and future directions.
    Thomas T; Bahadori T; Savage N; Thomas K
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2009; 1(4):426-33. PubMed ID: 20049808
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risks to health care workers from nano-enabled medical products.
    Murashov V; Howard J
    J Occup Environ Hyg; 2015; 12(6):D75-85. PubMed ID: 25950806
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advancing risk assessment of engineered nanomaterials: application of computational approaches.
    Gajewicz A; Rasulev B; Dinadayalane TC; Urbaszek P; Puzyn T; Leszczynska D; Leszczynski J
    Adv Drug Deliv Rev; 2012 Dec; 64(15):1663-93. PubMed ID: 22664229
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Creative use of analytical techniques and high-throughput technology to facilitate safety assessment of engineered nanomaterials.
    Liu Q; Wang X; Xia T
    Anal Bioanal Chem; 2018 Sep; 410(24):6097-6111. PubMed ID: 30066194
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nanomaterials in the environment: from materials to high-throughput screening to organisms.
    Thomas CR; George S; Horst AM; Ji Z; Miller RJ; Peralta-Videa JR; Xia T; Pokhrel S; Mädler L; Gardea-Torresdey JL; Holden PA; Keller AA; Lenihan HS; Nel AE; Zink JI
    ACS Nano; 2011 Jan; 5(1):13-20. PubMed ID: 21261306
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of the potential human health risks from exposure to complex substances in accordance with REACH requirements. "White spirit" as a case study.
    McKee RH; Tibaldi R; Adenuga MD; Carrillo JC; Margary A
    Regul Toxicol Pharmacol; 2018 Feb; 92():439-457. PubMed ID: 29069582
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modeling approaches for characterizing and evaluating environmental exposure to engineered nanomaterials in support of risk-based decision making.
    Hendren CO; Lowry M; Grieger KD; Money ES; Johnston JM; Wiesner MR; Beaulieu SM
    Environ Sci Technol; 2013 Feb; 47(3):1190-205. PubMed ID: 23293982
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of the occupational, consumer and environmental exposure to engineered nanomaterials used in 10 technology sectors.
    Nowack B; Brouwer C; Geertsma RE; Heugens EH; Ross BL; Toufektsian MC; Wijnhoven SW; Aitken RJ
    Nanotoxicology; 2013 Sep; 7(6):1152-6. PubMed ID: 22783888
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel method to prevent secondary exposure of medical and rescue personnel to toxic materials under biochemical hazard conditions using microwave radar and infrared thermography.
    Matsui T; Hagisawa K; Ishizuka T; Takase B; Ishihara M; Kikuchi M
    IEEE Trans Biomed Eng; 2004 Dec; 51(12):2184-8. PubMed ID: 15605866
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overview of neurotoxicology.
    Tilson HA
    Curr Protoc Toxicol; 2001 May; Chapter 11():Unit11.1. PubMed ID: 20957638
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Modern toxicology of magnetic nanomaterials].
    Cywińska MA; Grudziński IP
    Rocz Panstw Zakl Hig; 2012; 63(3):247-56. PubMed ID: 23173329
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Toxic effects of chemical mixtures.
    Zeliger HI
    Arch Environ Health; 2003 Jan; 58(1):23-9. PubMed ID: 12747515
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Towards a nanospecific approach for risk assessment.
    Dekkers S; Oomen AG; Bleeker EA; Vandebriel RJ; Micheletti C; Cabellos J; Janer G; Fuentes N; Vázquez-Campos S; Borges T; Silva MJ; Prina-Mello A; Movia D; Nesslany F; Ribeiro AR; Leite PE; Groenewold M; Cassee FR; Sips AJ; Dijkzeul A; van Teunenbroek T; Wijnhoven SW
    Regul Toxicol Pharmacol; 2016 Oct; 80():46-59. PubMed ID: 27255696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.